Cyclacel Pharmaceuticals, Inc. (CYCC) - NASDAQ
  • Colin Macleod | Send Message 7 Jun

    Clay Trader Cyclacel Pharmaceuti - $CYCC Stock Chart Technical Analysis for 06-06-16
      • Colin Macleod | Send Message 6 Jun

        Greatstockpix Watch List Video for June 7th $BOSC $BWEN $SWHC $TTNP $CONN $JVA $CYCC $SPEX $CLRB $WGBS $VBLT
          • radicfa | Send Message 6 Jun

            what is happening with $CYCC . it is up 84%
              • timothy russell | Send Message 6 Jun

                $CYCC told you! Killing it today, FAT profit after FAT profit! First $MOC and $VBLT now $CYCC
                  • timothy russell | Send Message 6 Jun

                    $CYCC wild - halt - wild - halt ...
                      • theoptionrider | Send Message 11 Mar 2015

                        Wednesday trade update - $TWTR $CYCC $STLD $DDD $PM $CSIQ
                          • PatrickTS | Send Message 2 Mar 2015

                            Few tickers for 2.03.2015: $FLWS $CYCC $EYES $UNXL $CLNE $ARQL $ZIOP
                              • Stephen Simpson, CFA | Send Message 18 Dec 2014

                                Cyclacel Now An Exercise In Futility $CYCC
                                  • Investor RockieK | Send Message 16 Dec 2014

                                    $TLOG $CYCC I'm not smart enough to follow these Pharm/Bio co's and too scared to super thin stocks.
                                      • aaliyaplasticsurgery | Send Message 4 Nov 2014

                                        $CYCC going to $10 by December 1, 2014
                                        Reply (1)
                                        • wrc123 | Send Message 8 Nov 2014
                                          : Why?
                                          Company Description
                                          Cyclacel Pharmaceuticals, Inc. is a diversified biopharmaceutical business focused in hematology and oncology based on a development pipeline of novel drug candidates. It is engaged in discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States